Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...

IQVIA Holdings Inc (IQV) reports robust financial performance with record free cash flow and strategic partnership renewals, ...

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Q4 2024. Management View. CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a ...

Growth in the Research and Development, and Technology and Analytics segments aids IQV's top line in the fourth quarter of 2024.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

let's now explore the average estimates of specific IQVIA metrics that are commonly monitored and projected by Wall Street analysts. Analysts' assessment points toward 'Revenues- Technology ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.